LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
1138
via prnewswire.comBusiness & Companies

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2026

FROM THE WIRE · PRNEWSWIRE.COM

Net revenues of $207.6 million for the three months ended September 30, 2026 GAAP net income of $37.8 million, or $0.87 per share, for the third quarter Adjusted non-GAAP net income of $49.3 million, or $1.14 per share, for the third quarter Company to hold a conference call…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishGAAP and adjusted earnings per share reported, relevant for the pharma stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01Net revenues were $207.6 million for the three months ended September 30, 2026.
  2. 02GAAP net income was $37.8 million, or $0.87 per share.
  3. 03Adjusted non-GAAP net income was $49.3 million, or $1.14 per share.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.